Axillary Lymph Clinical Trials

1 recruiting

Axillary Lymph Trials at a Glance

7 actively recruiting trials for axillary lymph are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Alcalá de Henares, Badalona, and Barakaldo. Lead sponsors running axillary lymph studies include The First Affiliated Hospital with Nanjing Medical University, Endomagnetics Ltd., and Hospital Universitari de Bellvitge.

Browse axillary lymph trials by phase

Treatments under study

About Axillary Lymph Clinical Trials

Looking for clinical trials for Axillary Lymph? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Axillary Lymph trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Axillary Lymph clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

Breast CancerRadiotherapy Side EffectSentinel Lymph Node+2 more
Hospital Universitari de Bellvitge820 enrolled60 locationsNCT04889924
Recruiting

Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery

Breast CancerSentinel Lymph Node Biopsy (SLNB)Axillary Lymph Nodes Dissection+1 more
University Hospitals of Derby and Burton NHS Foundation Trust200 enrolled12 locationsNCT07085442
Recruiting
Not Applicable

Omission of ALND in Breast Cancer Patients With Axillary pCR

Breast CancerAxillary Lymph Node DissectionPathological Complete Response+2 more
The First Affiliated Hospital with Nanjing Medical University92 enrolled1 locationNCT05939830
Recruiting
Not Applicable

Omission of SLNB in CN0 Early Breast Cancer

Breast CancerSentinel Lymph NodeClinically Assessed Negative Axillary Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University311 enrolled1 locationNCT05935150
Recruiting
Not Applicable

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

Breast CancerAxillary Lymph Nodes
Endomagnetics Ltd.65 enrolled2 locationsNCT03796559
Recruiting
Phase 4

The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage

Breast CancerHemopatchAxillary Lymphadenectomy
Instituto de Investigación Hospital Universitario La Paz118 enrolled1 locationNCT04904653
Recruiting
Not Applicable

Nomogram to Predict Breast Cancer Related Lymphedema

Breast CancerAxillary Lymph Node DissectionBreast Cancer Related Lymphedema+1 more
Wuhan University600 enrolled1 locationNCT04665882